Patent details

EP3010529 Title: USE OF UNACYLATED GHRELIN, FRAGMENTS AND ANALOGS THEREOF AS ANTIOXIDANT

  • Data
  • Documents

Basic Information

Publication number:
EP3010529
PCT Application Number:
IB2014001538
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP147998785
PCT Publication Number:
WO2014203074
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF UNACYLATED GHRELIN, FRAGMENTS AND ANALOGS THEREOF AS ANTIOXIDANT
French Title of Invention:
UTILISATION DE GHRÉLINE NON ACÉTYLÉE, DE SES FRAGMENTS ET SES ANALOGUES COMME AGENTS ANTIOXYDANTS
German Title of Invention:
VERWENDUNG VON NICHTACYLIERTEM GHRELIN SOWIE FRAGMENTEN UND ANALOGEN DAVON ALS ANTIOXIDANTIEN
SPC Number:

Dates

Filing date:
20/06/2014
Grant date:
06/05/2020
EP Publication Date:
27/04/2016
PCT Publication Date:
24/12/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/05/2020
EP B1 Publication Date:
06/05/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/06/2020
Expiration date:
20/06/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/04/2020
 
 

Name:
Millendo Therapeutics SAS
Address:
15, Chemin du Saquin Espace Européen, 69130 Ecully, France (FR)

Inventor

1

Name:
BRIZZI, Maria Felice
Address:
Italy (IT)

2

Name:
GHIGO, Ezio
Address:
Italy (IT)

Priority

Priority Number:
201361837723 P
Priority Date:
21/06/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/25; A61P 9/00;

Publication

European Patent Bulletin

Issue number:
202019
Publication date:
06/05/2020
Description:
Grant (B1)
Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer: